Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
Abstract Background The aim of this study was to construct a model based on the prognostic features associated with epithelial–mesenchymal transition (EMT) to explore the various mechanisms and therapeutic strategies available for the treatment of metastasis and invasion by hepatocellular carcinoma...
Guardado en:
Autores principales: | Dafeng Xu, Yu Wang, Jincai Wu, Shixun Lin, Yonghai Chen, Jinfang Zheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7db4f30d144f4431a78638ec27c454dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma
por: Divya Jain, et al.
Publicado: (2021) -
Progress in stem cell-derived technologies for hepatocellular carcinoma
por: Rajagopal N Aravalli
Publicado: (2010) -
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Jianyong Zhuo, et al.
Publicado: (2021) -
MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness
por: Seongki Min, et al.
Publicado: (2021) -
ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY
por: Danfei Liu, et al.
Publicado: (2021)